康(kang)希(xi)諾(nuo)生(sheng)物(wu)發布(bu)2022年(nian)上半年(nian)業績報告，收(shou)入同(tong)(tong)(tong)比(bi)下(xia)(xia)降(jiang)69.5%，半年(nian)凈(jing)利(li)潤(run)同(tong)(tong)(tong)比(bi)下(xia)(xia)降(jiang)98.7%。上半年(nian)收(shou)入從去年(nian)同(tong)(tong)(tong)期(qi)的(de)20.6億(yi)元(yuan)(yuan)人民(min)幣下(xia)(xia)降(jiang)至(zhi)6.298億(yi)元(yuan)(yuan)，業績下(xia)(xia)滑主要(yao)由于(yu)全球(qiu)疫苗使用量增長放緩(huan)以及(ji)產品價格變化導致疫苗需(xu)求疲軟。歸母凈(jing)利(li)潤(run)1223.8萬(wan)元(yuan)(yuan)，同(tong)(tong)(tong)比(bi)降(jiang)98.69%；歸母扣非凈(jing)利(li)潤(run)由盈(ying)轉虧5676.9萬(wan)元(yuan)(yuan)，同(tong)(tong)(tong)比(bi)下(xia)(xia)降(jiang)106.31%。(全球(qiu)企業動態)